Interleukin 2 expression by tumor cells alters both the immune response and the tumor microenvironment

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1478-1485

  Lee, Jungeun ^a   Fenton, Bruce M ^a   Koch, Cameron J ^b   Frelinger, John G ^a   Lord, Edith M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CANCER; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE; TUMOR GROWTH;

EID: 0032054277     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Overgaard, J., Hansen, H. S., Jorgensen, K., and Hjelm Hansen, M. Primary radiotherapy of larynx and pharynx carcinoma: an analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys., 12: 515-521, 1986.
2. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Washington DC), 240: 177-84, 1988.
3. Vaupel, P. W., Frinak, S., and Bicher, H. I. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res., 41: 2008-2013, 1981.
4. Loeffler, D. A., Keng, P. C., Baggs, R. B., and Lord, E. M. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor. Int. J. Cancer, 45: 462-467, 1990.
5. Loeffler, D. A., Juneau, P. L., and Heppner, G. H. Natural killer-cell activity under conditions reflective of tumor micro-environment. Int. J. Cancer, 48: 895-899, 1991.
6. Loeffler, D. A., Juneau, P. L., and Masserant, S. Influence of tumour physicochemical conditions on interleukin-2-stimulated lymphocyte proliferation. Br. J. Cancer, 66: 619-622, 1992.
7. Zuckerberg, A. L., Goldberg, L. I., and Lederman, H. M. Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit. Care Med., 22: 197-203, 1994.
8. Nathan, C. F., Mercer-Smith, J. A., Desantis, N. M., and Palladino, M. A. Role of oxygen in T cell-mediated cytolysis. J. Immunol., 129: 2164-2171, 1982.
9. Evans, S. M., Joiner, B., Jenkins, W. T., Laughlin, K. M., Lord, E. M., and Koch, C. J. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. Br. J. Cancer, 72: 875-882, 1995.
10. Laughlin, K. M., Evans, S. M., Jenkins, W. T., Tracy, M., Chan, C. Y., Lord, E. M., and Koch, C. J. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. J. Pharmacol. Exp. Ther., 277: 1049-1057, 1996.
11. Lee, J., Siemann, D. W., Koch, C. J., and Lord, E. M. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int. J. Cancer, 67: 372-378, 1996.
12. Lord, E. M., Harwell, L., and Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53: 5721-5726, 1993.
13. Gunning, P., Leavitt, J., Muscat, G., Ng, S. Y., and Kedes, L. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA, 84: 4831-4835, 1987.
14. Yokota, T., Arai, N., Lee, F., Rennick, D., Mosmann, T., and Arai, K. Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc. Natl. Acad. Sci. USA, 82: 68-72, 1985.
15. Rockwell, S. C., Kallman, R. F., and Fajardo, L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. (Bethesda), 49: 735-749, 1972.
16. Kiessling, R., Klein, E., and Wigzell, H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol., 5: 112-117, 1975.
17. Plaut, M., Lichtenstein, L. M., Gillespie, E., and Henney. C. S. Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J. Immunol., 111: 389-394, 1973.
18. McAdam, A. J., Felcher, A., Woods, M. L., Pulaski, B. A., Hutter, E. K., Frelinger, J. G., and Lord, E. M. Transfection of transforming growth factor-β producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. J. Immunother., 15: 155-164, 1994.
19. Maryanski, J. L., Van Snick, J., Cerottini, J. C., and Boon, T. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur. J. Immunol., 12: 401-406, 1982.
20. Koch, C. J., Evans, S. M., and Lord, E. M. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs. bound radioactivity. Br. J. Cancer, 72: 869-874, 1995.
21. Trotter, M. J., Chaplin, D. J., Durand, R. E., and Olive, P. L. The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int. J. Radiat. Oncol. Biol. Phys., 16: 931-934, 1989.
22. Rijken, P. F., Bernsen, H. J., and van der Kogel, A. J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc. Res., 50: 141-153, 1995.
23. Fenton, B. M., and Way, B. A. Vascular morphometry of KHT and RIF-1 murine sarcomas. Radiother. Oncol., 28: 57-62, 1993.
24. Kayar, S. R., Archer, P. G., Lechner, A. J., and Banchero, N. The closest-individual method in the analysis of the distribution of capillaries. Microvasc. Res., 24: 326-341, 1982.
25. Vaupel, P. W. Oxygenation of solid tumors. In: B, A. Teicher (ed.), Drug Resistance in Oncology, pp. 53-85. New York: Marcel Dekker, Inc, 1993.
26. Edwards, M. J., Miller, F. N., Sims, D. E., Abney, D. L., Schuschke, D. A., and Corey, T. S. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res., 52: 3425-3431, 1992.
27. Rosenstein, M., Ettinghausen, S. E., and Rosenberg, S. A. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J. Immunol., 137: 1735-1742, 1986.
28. Cotran, R. S., Pober, J. S., Gimbrone, M. A., Jr., Springer, T. A., Wiebke, E. A., Gaspari, A. A., Rosenberg, S. A., and Lotze, M. T. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J. Immunol., 140: 1883-1888, 1988.
29. Edwards, M. J., Schuschke, D. A., Abney, D. L., and Miller. F. N. Interleukin-2 acutely induces protein leakage from the microcirculation. J. Surg. Res., 50: 609-615, 1991.
30. Ohkubo, C., Bigos, D., and Jain, R. K. Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res., 51: 1561-1563, 1991.
31. Federspiel, W. J., and Popel, A. S. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc. Res.. 32: 164-189, 1986.
32. Degner, F. L., and Sutherland, R. M. Mathematical modelling of oxygen supply and oxygenation in tumor tissues: prognostic, therapeutic, and experimental implications. Int. J. Radiat. Oncol. Biol. Phys., 15: 391-397, 1988.
33. Hicks, C., Breit, S. N., and Penny, R. Response of microvascular endothelial cells to biological response modifiers. Immunol. Cell Biol., 67: 271-277, 1989.
34. Hicks, C., Cooley, M. A., and Penny, R. Investigation of interleukin 2 receptors on human endothelial cells. Growth Factors, 5: 201-208, 1991.
35. Cozzolino, F., Torcia, M., Lucibello, M., Morbidelli, L., Ziehe, M., Platt, J., Fabiani, S., Brett, J., and Stern, D. Interferon-α and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J. Clin. Invest., 91: 2504-2512, 1993.
36. Epstein, R. J., Hendricks, R. L., and Stulting, R. D. Interleukin-2 induces corneal neovascularization in A/J mice. Cornea, 9: 318-323, 1990.
37. Hanisch, U. K., Neuhaus, J., Quirion, R., and Kettenmann, H. Neurotoxicity induced by interleukin-2: involvement of infiltrating immune cells. Synapse, 24: 104-114, 1996.
38. MacKenzie, W. M., Hoskin, D. W., and Blay, J. Adenosine inhibits the adhesion of anti-CDS-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res., 54: 3521-3526, 1994.
39. MacDonald, H. R., and Koch, C. J. Energy metabolism and T-cell-mediated cytolysis. I. Synergism between inhibitors of respiration and glycolysis. J. Exp. Med., 146: 698-709, 1977.
40. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
41. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.